nach oben

Archives of Women's Mental Health

Erschienen in:

01.02.2013 | Original Article

Cognitive performance in healthy women during induced hypogonadism and ovarian steroid addback

verfasst von: Peter J. Schmidt, P. A. Keenan, Linda A. Schenkel, Kate Berlin, Carolyn Gibson, David R. Rubinow

Erschienen in: Archives of Women's Mental Health | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Gynecology clinic-based studies have consistently demonstrated that induced hypogonadism is accompanied by a decline in cognitive test performance. However, a recent study in healthy asymptomatic controls observed that neither induced hypogonadism nor estradiol replacement influenced cognitive performance. Thus, the effects of induced hypogonadism on cognition might not be uniformly experienced across individual women. Moreover, discrepancies in the effects of hypogonadism on cognition also could suggest the existence of specific risk phenotypes that predict a woman’s symptomatic experience during menopause. In this study, we examined the effects of induced hypogonadism and ovarian steroid replacement on cognitive performance in healthy premenopausal women. Ovarian suppression was induced with a GnRH agonist (Lupron) and then physiologic levels of estradiol and progesterone were reintroduced in 23 women. Cognitive tests were administered during each hormone condition. To evaluate possible practice effects arising during repeated testing, an identical battery of tests was administered at the same time intervals in 11 untreated women. With the exception of an improved performance on mental rotation during estradiol, we observed no significant effects of estradiol or progesterone on measures of attention, concentration, or memory compared with hypogonadism. In contrast to studies in which a decline in cognitive performance was observed in women receiving ovarian suppression therapy for an underlying gynecologic condition, we confirm a prior report demonstrating that short-term changes in gonadal steroids have a limited effect on cognition in young, healthy women. Differences in the clinical characteristics of the women receiving GnRH agonists could predict a risk for ovarian steroid-related changes in cognitive performance during induced, and possibly, natural menopause.

Nur mit Berechtigung zugänglich

Abraham GE, Swerdloff R, Tulchinsky D, Odell WD (1971) Radioimmunoassay of plasma progesterone. J Clin Endocrinol Metab 32:619–624PubMedCrossRef

Bagger YZ, Tanko LB, Alexandersen P, Qin G, Christiansen C (2005) Early postmenopausal hormone therapy may prevent cognitive impairment later in life. Menopause 12:12–17PubMedCrossRef

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMedCrossRef

Benton AL, Hamsher K (1976) Multilingual aphasia examination. AJA, Iowa City

Benton AL, Hamsher K, Varney NR, Spreen O (1983) Contributions to neuropsychological assessment. Oxford University Press, New York

Berman KF, Schmidt PJ, Rubinow DR, Danaceau MA, Van Horn JD, Esposito G, Ostrem JL, Weinberger DR (1997) Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc Natl Acad Sci USA 94:8836–8841PubMedCrossRef

Cavallini A, Resta L, Caringella AM, Dinaro E, Lippolis C, Loverro G (2011) Involvement of estrogen receptor-related receptors in human ovarian endometriosis. Fertil Steril 96:102–106PubMedCrossRef

Corwin J, Bylsma FW (1993) Translations of excerpts from André Rey’s psychological examination of traumatic encephalopathy and P.A. Osterrieth’s the complex figure copy test. Clin Neuropsychol 7:3–21CrossRef

Craig MC, Fletcher PC, Daly EM, Rymer J, Cutter WJ, Brammer M, Giampietro V, Wickham H, Maki PM, Murphy DGM (2007) Gonadotropin hormone releasing hormone agonists alter prefrontal function during verbal encoding in young women. Psychoneuroendocrinology 32:1116–1127PubMedCrossRef

Craig MC, Fletcher PC, Daly EM, Picchioni MM, Brammer M, Giampietro V, Rymer J, McGuire PK, Maki PM, Murphy DGM (2008a) A study of visuospatial working memory pre- and post-gonadotropin hormone releasing hormone agonists (GnRHa) in young women. Horm Behav 54:47–59PubMedCrossRef

Craig MC, Fletcher PC, Daly EM, Rymer J, Brammer M, Giampietro V, Maki PM, Murphy DGM (2008b) Reversibility of the effects of acute ovarian hormone suppression on verbal memory and prefrontal function in pre-menopausal women. Psychoneuroendocrinology 33:1426–1431PubMedCrossRef

Diaz Brinton R (2009) Estrogen-induced plasticity from cells to circuits: predications for cognitive function. Trends Pharmacol Sci 30:212–222CrossRef

Duka T, Tasker R, McGowan JF (2000) The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology 149:129–139PubMedCrossRef

Dumitriu D, Rapp PR, McEwen BS, Morrison JH (2010) Estrogen and the aging brain: an elixir for the weary cortical network. Ann N Y Acad Sci 1204:104–112PubMedCrossRef

Eberling JL, Reed BR, Coleman JE, Jagust WJ (2000) Effect of estrogen on cerebral glucose metabolism in postmenopausal women. Neurology 55:875–877PubMedCrossRef

Endicott J, Halbreich U, Schacht S, Nee J (1981) Premenstrual changes and affective disorders. Psychosom Med 43:519–529PubMed

Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J (2004) Conjugated equine estrogens and global cognitive function in postmenopausal women: Women’s Health Initiative Memory Study. J A M A 291:2959–2968PubMedCrossRef

Fuh JL, Wang SJ, Lee SJ, Lu SR, Juang KD (2006) A longitudinal study of cognition change during early menopausal transition in a rural community. Maturitas 53:447–453PubMedCrossRef

Furuyama S, Mayes DM, Nugent CA (1970) A radioimmunoassay for plasma testosterone. Steroids 16:415–428PubMedCrossRef

Gibbs RB (2010) Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocr Rev 31:224–253PubMedCrossRef

Gold EG, Sternfeld B, Kelsey JL, Brown C, Mouton C, Reame N, Salamone L, Stellato R (2000) Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. Am J Epidemiol 152:463–473PubMedCrossRef

Goldstein JM, Jerram M, Poldrack R, Ahern T, Kennedy DN, Seidman LJ, Makris N (2005) Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J Neurosci 25:9309–9316PubMedCrossRef

Green P, Kramer E (1983) Auditory comprehension tests. Auditory Comprehension Tests, Ltd., Edmonton

Grigorova M, Sherwin BB, Tulandi T (2006) Effects of treatment with leuprolide acetate depot on working memory with executive functions in young premenopausal women. Psychoneuroendocrinology 31:935–947PubMedCrossRef

Hampson E, Kimura D (1988) Reciprocal effects of hormonal fluctuations on human motor and perceptual–spatial skills. Behav Neurosci 102:456–459PubMedCrossRef

Harley JP, Leuthold CA, Matthews CG, Bergs LE (1980) Wisconsin neuropsychological test battery T-score norms for older veterans administration medical center patients. Department of Neurology, University of Wisconsin Medical School, Madison

Henderson VW, Guthrie JR, Dudley EC, Burger HG, Dennerstein L (2003) Estrogen exposures and memory at midlife: a population-based study of women. Neurology 60:1369–1371PubMedCrossRef

Henderson VW, Benke KS, Green RC, Cupples LA, Farrer LA (2005) Postmenopausal hormone therapy and Alzheimer’s disease risk: interaction with age. J Neurol Neurosurg Psychiatry 76:103–105PubMedCrossRef

Hogervorst E, Yaffe K, Richards M, Huppert F (2002) Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst RevCD003122

Huhtinen K, Ståhle M, Perheentupa A, Poutanen M (2011) Estrogen biosynthesis and signaling in endometriosis. Mol Cell Endocrinol 358(2):146–154. doi: 10.1016/j.mce.2011.08.022

Jastak S, Wilkinson GS (1984) Wide range achievement test-revised. Jastak Assessment Systems, Wilmington

Jiang N-S, Ryan PJ (1969) Radioimmunoassay for estrogens: a preliminary communication. Mayo Clin Proc 44:461–465PubMed

Joffe H, Hall JE, Gruber S, Sarmiento IA, Cohen LS, Yurgelun-Todd D, Martin KA (2006) Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause 13:411–422PubMedCrossRef

Kampen DL, Sherwin BB (1994) Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 83:979–983PubMedCrossRef

Keenan PA, Stern RA, Janowsky DS, Pedersen CA (1992) Psychological aspects of premenstrual syndrome I: cognition and memory. Psychoneuroendocrinology 17:179–187PubMedCrossRef

Keenan PA, Lindamer LA, Jong SK (1995) Menstrual phase-independent retrieval deficit in women with PMS. Biol Psychiatry 38:369–377PubMedCrossRef

Keenan PA, Ezzat WH, Ginsburg K, Moore GJ (2001) Prefrontal cortex as the site of estrogen’s effect on cognition. Psychoneuroendocrinology 26:577–590PubMedCrossRef

Kelly MJ, Ronnekleiv OK (2009) Control of CNS neuronal excitability by estrogens via membrane-initiated signaling. Mol Cell Endocrinol 308:17–25PubMedCrossRef

Kløve H (1963) Clinical neuropsychology. In: Forster FM (ed) The medical clinics of North America. Saunders, New York, pp 1647–1658

Kok HS, Kuh D, Cooper R, van der Schouw YT, Grobbee DE, Wadsworth MEJ, Richards M (2006) Cognitive function across the life course and the menopausal transition in a British birth cohort. Menopause 13:19–27PubMedCrossRef

Korol DL, Kolo LL (2002) Estrogen-induced changes in place and response learning in young adult female rats. Behav Neurosci 116:411–420PubMedCrossRef

Kramer JH, Delis DC, Blusewicz MJ, Brandt J, Ober BA, Strauss M (1988) Verbal memory errors in Alzheimer’s and Huntington’s dementias. Dev Neuropsychol 4:1–15CrossRef

LeBlanc ES, Janowsky J, Chan BKS, Nelson HD (2001) Hormone replacement therapy and cognition: systematic review and meta-analysis. J A M A 285:1489–1499PubMedCrossRef

LeBlanc ES, Neiss MB, Carello PE, Samuels MH, Janowsky JS (2007) Hot flashes and estrogen therapy do not influence cognition in early menopausal women. Menopause 14:191–202PubMedCrossRef

Lethaby A, Hogervorst E, Richards M, Yesufu A, Yaffe K (2008) Hormone replacement therapy for cognitive function in postmenopausal women (review). Cochrane Database Syst Rev 1:CD003122PubMed

Lezak Deutsch M (1995) Neuropsychological assessment third edition. Oxford University Press, New York

Li S, McLachlan JA (2001) Estrogen-associated genes in uterine leiomyoma. Ann N Y Acad Sci 948:112–120PubMedCrossRef

Low L-F, Anstey KJ (2006) Hormone replacement therapy and cognitive performance in postmenopausal women—a review by cognitive domain. Neurosci Biobehav Rev 30:66–84PubMedCrossRef

MacLennan AH, Henderson VW, Paine BJ, Mathias J, Ramsay EN, Ryan P, Stocks NP, Taylor AW (2006) Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause 13:28–36PubMedCrossRef

Maki PM, Resnick SM (2000) Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging 21:373–383PubMedCrossRef

Maki PM, Zonderman AB, Resnick SM (2001) Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. Am J Psychiatry 158:227–233PubMedCrossRef

Maki PM, Gast MJ, Vieweg AJ, Burriss SW, Yaffe K (2007) Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial. Neurology 69:1322–1330PubMedCrossRef

Maki PM, Drogos LL, Rubin LH, Banuvar S, Shulman LP, Geller SE (2008) Objective hot flashes are negatively related to verbal memory performance in midlife women. Menopause 15:848–856PubMedCrossRef

McEwen BS (2010) Stress, sex, and neural adaptation to a changing environment: mechanisms of neuronal remodeling. Ann N Y Acad Sci 1204:E38–E59PubMedCrossRef

Mitchell ES, Woods NF (2001) Midlife women’s attributions about perceived memory changes: observations from the Seattle midlife women’s health study. J Women’s Health Gend Based Med 10:351–362CrossRef

Money J (1976) A standardized road map test of direction sense. Manual. Academic Therapy Publications, San Rafael

Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ (2000) Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. J A M A 283:1007–1015PubMedCrossRef

Owens JF, Matthews KA, Everson SA (2002) Cognitive function effects of suppressing ovarian hormones in young women. Menopause 9:227–235PubMedCrossRef

Palomba S, Orio F Jr, Russo T, Falbo A, Amati A, Zullo F (2004) Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood, and quality of life. Fertil Steril 82:480–482PubMedCrossRef

Phillips SM, Sherwin BB (1992) Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17:485–495PubMedCrossRef

Porteus SD (1959) The maze test and clinical psychology. Pacific Books, Palo Alto

Protopopescu X, Pan H, Altemus M, Tuescher O, Polanecsky M, McEwen B, Silbersweig D, Stern E (2005) Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle. Proc Natl Acad Sci USA 102:16060–16065PubMedCrossRef

Rapp PR, McKay H, Kansky MT, Roberts JA (2002) Ovarian hormone status modulates the cognitive outcome of aging in the rhesus monkey. Abstr Soc Neurosci

Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass MLS, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D (2003) Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial. J A M A 289:2663–2672PubMedCrossRef

Rasgon NL, Silverman D, Siddarth P, Miller K, Ercoli LM, Elman S, Lavretsky H, Huang SC, Phelps ME, Small GW (2005) Estrogen use and brain metabolic change in postmenopausal women. Neurobiol Aging 26:229–235PubMedCrossRef

Reitan RM (1958) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271–276

Reitan RM, Wolfson D (1993) The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. Neuropsychology Press, Tucson

Resnick SM, Metter EJ, Zonderman AB (1997) Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect? Neurology 49:1491–1497PubMedCrossRef

Resnick SM, Maki PM, Golski S, Kraut MA, Zonderman AB (1998) Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm Behav 34:171–182PubMedCrossRef

Shaywitz SE, Shaywitz BA, Pugh KR, Fulbright RK, Skudlarski P, Mencl WE, Constable RT, Naftolin F, Palter SF, Marchione KE, Katz L, Shankweiler DP, Fletcher JM, Lacadie C, Keltz M, Gore JC (1999) Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. J A M A 281:1197–1202PubMedCrossRef

Shepard RN, Metzler J (1971) Mental rotation of three-dimensional objects. Science 171:701–703PubMedCrossRef

Sherwin BB (1988) Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 13:345–357PubMedCrossRef

Sherwin BB, Tulandi T (1996) “Add-back” estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab 81:2545–2549PubMedCrossRef

Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN III, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J (2003) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial. J A M A 289:2651–2662PubMedCrossRef

Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH (2004) Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: women’s health initiative memory study. J A M A 291:2947–2958PubMedCrossRef

Smith A (1982) Symbol digit modalities test (SDMT) manual (revised). Western Psychological Services, Los Angeles

Smith YR, Love T, Persad CC, Tkaczyk A, Nichols TE, Zubieta JK (2006) Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging. J Clin Endocrinol Metab 91:4476–4481PubMedCrossRef

Spitzer RL, Williams JB, Gibbon M, First MB (1990) Structured clinical interview for DSM-III-R, patientth edn. Biometrics Research Department, New York State Psychiatric Institute, New York

Spreen O, Benton AL (1969) Embedded figures test. Neuropsychological Laboratory, University of Victoria, Victoria

Spreen O, Strauss E (1991) A compendium of neuropsychological tests. Oxford University Press, New York

Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643–662CrossRef

Talland GA (1965) Reproduction and distortion of narrative texts. Deranged memory: a psychonomic study of the amnesic syndrome. Academic, New York, pp 235–243

Tinkler GP, Tobin JR, Voytko ML (2002) Cholinergic neurons in the nucleus basalis following two-year estrogen loss or replacement in surgically menopausal monkeys. Abstr Soc Neurosci

van Wingen G, van Broekhoven F, Verkes RJ, Petersson KM, Backstrom T, Buitelaar J, Fernandez G (2007) How progesterone impairs memory for biologically salient stimuli in healthy young women. J Neurosci 27:11416–11423PubMedCrossRef

Vandenberg SG, Kuse AR (1978) Mental rotations, a group test of three-dimensional spatial visualization. Percept Mot Skills 47:599–604PubMedCrossRef

Varney NR, Syrop C, Kubu CS, Struchen M, Hahn S, Franzen K (1993) Neuropsychological dysfunction in women following leuprolide acetate induction of hypoestrogenism. J Assist Reprod Genet 10:53–57PubMedCrossRef

Wechsler D (1981) Wechsler adult intelligence scale—revised. The Psychological Corporation, Harcourt Brace Jovanovich, Inc, San Antonio

Wechsler D (1987) Wechsler memory scale-revised manual. The Psychological Corporation, San Antonio

Wei T, Geiser AG, Qian HR, Su C, Helvering LM, Kulkarini NH, Shou J, N’Cho M, Bryant HU, Onyia JE (2007) DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids. BMC Womens Health 7:5PubMedCrossRef

Whitmer RA, Quesenberry CP Jr, Zhou J, Yaffe K (2011) Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol 69:163–169PubMedCrossRef

Wise PM, Dubal DB, Rau SW, Brown CM, Suzuki S (2005) Are estrogens protective or risk factors in brain injury and neurodegeneration? Reevaluation after the women’s health initiative. Endocr Rev 26:308–312PubMedCrossRef

Yaffe K, Sawaya G, Lieberburg I, Grady D (1998) Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. J A M A 279:688–695PubMedCrossRef

Yaffe K, Vittinghoff E, Ensrud KE, Johnson KC, Diem S, Hanes V, Grady D (2006) Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life. Arch Neurol 63:945–950PubMedCrossRef

Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JCS (2002) Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County study. J A M A 288:2123–2129PubMedCrossRef

Titel: Cognitive performance in healthy women during induced hypogonadism and ovarian steroid addback
verfasst von: Peter J. Schmidt
P. A. Keenan
Linda A. Schenkel
Kate Berlin
Carolyn Gibson
David R. Rubinow
Publikationsdatum: 01.02.2013
Verlag: Springer Vienna
Erschienen in: Archives of Women's Mental Health / Ausgabe 1/2013
Print ISSN: 1434-1816
Elektronische ISSN: 1435-1102
DOI: https://doi.org/10.1007/s00737-012-0316-9

Neu in den Fachgebieten Neurologie und Psychiatrie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2013

Mother–infant bonding impairment across the first 6 months postpartum: the primacy of psychopathology in women with childhood abuse and neglect histories

A systematic review of the nutritional status of women of a childbearing age with severe mental illness

Short forms of the Postpartum Depression Screening Scale: as accurate as the original form

Comorbid bipolar disorder and premenstrual dysphoric disorder: real patients, unanswered questions

Effects of quetiapine extended release on sleep and quality of life in midlife women with major depressive disorder

A pilot study of heart rate variability biofeedback therapy in the treatment of perinatal depression on a specialized perinatal psychiatry inpatient unit

Neu in den Fachgebieten Neurologie und Psychiatrie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Frühe Alzheimertherapie lohnt sich

Viel Bewegung in der Parkinsonforschung

Demenzkranke durch Antipsychotika vielfach gefährdet